ASX Growth Companies With Insider Ownership Up To 38%

Simply Wall St.03:08

As the Australian stock market experiences a modest rise amidst geopolitical uncertainties, investors are keeping a close watch on sectors poised for growth and resilience. In such an environment, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622895939?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","is_english":true,"pubTime":"2026-03-27 03:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622895939","market":"nz","top_or_hot":-1,"title":"ASX Growth Companies With Insider Ownership Up To 38%","media":"Simply Wall St.","content":"<div>\n<p>As the Australian stock market experiences a modest rise amidst geopolitical uncertainties, investors are keeping a close watch on sectors poised for growth and resilience. In such an environment, ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/asx-growth-companies-with-insider-ownership-up-to-38-2\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ASX Growth Companies With Insider Ownership Up To 38%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nASX Growth Companies With Insider Ownership Up To 38%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-27 03:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/asx-growth-companies-with-insider-ownership-up-to-38-2><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As the Australian stock market experiences a modest rise amidst geopolitical uncertainties, investors are keeping a close watch on sectors poised for growth and resilience. In such an environment, ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/asx-growth-companies-with-insider-ownership-up-to-38-2\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7017","symbol_name":"商品化工","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/asx-growth-companies-with-insider-ownership-up-to-38-2","article_id":"2622895939","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/asx-growth-companies-with-insider-ownership-up-to-38-2","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622895939","pubTimestamp":1774552107,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"As the Australian stock market experiences a modest rise amidst geopolitical uncertainties, investors are keeping a close watch on sectors poised for growth and resilience. In such an environment, companies with high insider ownership often attract attention due to the confidence they signal in their own potential, making them intriguing prospects for those seeking long-term growth opportunities.","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7017":"商品化工","BK4531":"中概回港概念","TOR.AU":"TORQUE METALS LTD","BK7007":"医疗保健设备","IQ":"爱奇艺","BK4526":"热门中概股","BK4139":"生物科技","BK7508":"医药生物股","BK7095":"多种金属与采矿","BK7104":"黄金","TLX":"Telix Pharmaceuticals Ltd. (Uplisting)","BK4505":"高瓴资本持仓","AR1.AU":"AUSTRAL RESOURCES AUSTRALIA","CYC.AU":"CYCLOPHARM LTD","BK7016":"应用软件","CUV.AU":"CLINUVEL PHARMACEUTICALS LTD","FRS.AU":"FORRESTANIA RESOURCES LTD","BK4108":"电影和娱乐","BK4552":"Archegos爆仓风波概念","REG.AU":"REGIS HEALTHCARE LTD","BK7067":"生物科技","AEM.AU":"Advanced Energy Minerals Ltd","BK7129":"钢铁","BK7110":"铜","TLX.AU":"TELIX PHARMACEUTICALS LTD","FEX.AU":"FENIX RESOURCES LTD","AV1.AU":"ADVERITAS LTD","EIQ.AU":"ECHOIQ LTD","BK7113":"保健护理机构","MAU.AU":"MAGNETIC RESOURCES NL"},"translate_title":"内部持股比例高达38%的ASX成长型公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FRS.AU":1,"TLX.AU":1,"AEM.AU":1,"EIQ.AU":1,"TLX":0.68,"IQ":0.78,"AV1.AU":1,"REG.AU":1,"TOR.AU":1,"CYC.AU":1,"MAU.AU":1,"AR1.AU":1,"CUV.AU":1,"FEX.AU":1},"content_text":"As the Australian stock market experiences a modest rise amidst geopolitical uncertainties, investors are keeping a close watch on sectors poised for growth and resilience. In such an environment, companies with high insider ownership often attract attention due to the confidence they signal in their own potential, making them intriguing prospects for those seeking long-term growth opportunities.AdvertisementTop 10 Growth Companies With High Insider Ownership In AustraliaNameInsider OwnershipEarnings GrowthTorque Metals (ASX:TOR)18.6%94.2%Magnetic Resources (ASX:MAU)33.6%124.2%Forrestania Resources (ASX:FRS)35.5%102.3%Fenix Resources (ASX:FEX)19.7%62.5%Echo IQ (ASX:EIQ)19.6%109.4%Cyclopharm (ASX:CYC)10.4%117.1%Clinuvel Pharmaceuticals (ASX:CUV)10.3%27.1%Austral Resources Australia (ASX:AR1)18.9%39.1%Adveritas (ASX:AV1)17.9%109.9%Advanced Energy Minerals (ASX:AEM)37.5%48.4%Click here to see the full list of 113 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Let's dive into some prime choices out of the screener.Echo IQ (ASX:EIQ)Simply Wall St Growth Rating: ★★★★★★Overview: Echo IQ Limited provides artificial intelligence diagnostics tools to improve the diagnosis of structural heart disease in Australia and has a market cap of A$589.12 million.Operations: Echo IQ Limited generates revenue primarily from the development of artificial intelligence software, amounting to A$0.09 million.Insider Ownership: 19.6%Echo IQ, recently added to the S&P/ASX All Ordinaries Index, is forecasted for significant growth with expected annual revenue increases of over 120%, outpacing the Australian market. Although it currently reports less than A$91K in revenue and a net loss of A$8.66 million for the last half-year, its projected profitability within three years and high future return on equity highlight potential as a growth company despite current financial challenges.Navigate through the intricacies of Echo IQ with our comprehensive analyst estimates report here.According our valuation report, there's an indication that Echo IQ's share price might be on the expensive side.ASX:EIQ Ownership Breakdown as at Mar 2026Regis Healthcare (ASX:REG)Simply Wall St Growth Rating: ★★★★★☆Overview: Regis Healthcare Limited provides residential aged care services in Australia and has a market cap of A$1.98 billion.Operations: The company generates revenue of A$1.26 billion from its residential aged care, home care, and retirement living services in Australia.Insider Ownership: 38.6%Regis Healthcare is positioned for growth, with insiders buying more shares than selling recently. Forecasted earnings growth of 23% annually outpaces the Australian market. Despite slower revenue growth at 8.7%, it exceeds market averages and supports strategic acquisitions and developments. Recent funding reforms and favorable demographics bolster its outlook, while a strong balance sheet aids expansion plans. The appointment of experienced healthcare executive Carmel Monaghan strengthens governance as Regis pursues long-term value creation for shareholders.Click to explore a detailed breakdown of our findings in Regis Healthcare's earnings growth report.The analysis detailed in our Regis Healthcare valuation report hints at an deflated share price compared to its estimated value.ASX:REG Ownership Breakdown as at Mar 2026Telix Pharmaceuticals (ASX:TLX)Simply Wall St Growth Rating: ★★★★☆☆Overview: Telix Pharmaceuticals Limited is a commercial-stage biopharmaceutical company that develops and commercializes therapeutic and diagnostic radiopharmaceuticals, with a market cap of A$4.38 billion.Operations: The company generates revenue from three primary segments: Therapeutics ($9.27 million), Precision Medicine ($621.93 million), and Manufacturing Solutions ($245.11 million).Insider Ownership: 14.9%Telix Pharmaceuticals is advancing its growth trajectory with significant insider ownership and strategic developments. The recent resubmission of the NDA for TLX101-Px to the FDA highlights its focus on addressing unmet medical needs in brain cancer imaging, supported by orphan drug and fast track designations. Although revenue growth is projected at 13.8% annually, slower than some peers, it surpasses market averages. Telix's profitability outlook within three years enhances its investment appeal amidst ongoing clinical advancements and regulatory pursuits.Delve into the full analysis future growth report here for a deeper understanding of Telix Pharmaceuticals.Our comprehensive valuation report raises the possibility that Telix Pharmaceuticals is priced lower than what may be justified by its financials.ASX:TLX Earnings and Revenue Growth as at Mar 2026Seize The OpportunityDive into all 113 of the Fast Growing ASX Companies With High Insider Ownership we have identified here.Want To Explore Some Alternatives? Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. \n    It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. \n    All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.Valuation is complex, but we're here to simplify it.Discover if Echo IQ might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622895939","isCrawlerRequest":true}